Funding for this research was provided by:
deutsche forschungsgemeinschaft (SFB824, SFB824, SFB824)
Technische Universität München
Received: 19 June 2021
Accepted: 15 August 2021
First Online: 28 August 2021
: All animal research cited was done after approval by the local animal welfare committee (for detailed informations please refer to the original publications). Comparative evaluation of human tissue specimen was performed after approval of the local ethics committee (77/17S).
: Consent to publish was obtained from all participants.
: Please contact the author for data requests.
: M.S. is a consultant/advisory board member for GE Healthcare. M.S. received a commercial research grant from Siemens Medical Research, received speakers' bureau honoraria from Siemens Lunch Symposium and has ownership interest (including patents) in Siemens. W.W. has received consultancy or advisory fees from Roche Pharma AG, MSD, BMS, AstraZeneca, Astrella, Takeda, Lilly and Boehringer Ingelheim and funding from Roche Pharma AG, BMS, MSD and Bruker. K.S is consultant for Roche Pharma AG and TRIMT and has filed a patent on a radiopharmaceutical. All other authors declare that they have no competing interests.